Literature DB >> 29458694

Persistent High Residual AHI After CPAP Use.

Leay Kiaw Er1,2, Shinn-Kuang Lin2,3, Stephen Shei-Dei Yang2,4, Chou-Chin Lan2,5, Yao-Kuang Wu2,5, Mei-Chen Yang2,5.   

Abstract

ABSTRACT: Treatment-emergent central sleep apnea has recently been noted after various treatment modalities for obstructive sleep apnea. It often remits spontaneously or can be treated with continuous positive airway pressure. However, we encountered a pediatric patient with obstructive sleep apnea who presented with severe complications, including growth failure, attention-deficit hyperactivity disorder, poor school performance, daytime sleepiness, and urinary difficulty that required permanent cystostomy. His obstructive sleep apnea resolved after adenotonsillectomy. However, treatment-emergent central sleep apnea developed after adenotonsillectomy and was further aggravated after continuous positive airway pressure and bilevel positive airway pressure without a backup respiratory rate use. After bilevel positive airway pressure with a backup respiratory rate treatment for 3 months initially, all his symptoms improved, except growth failure. Later, after adaptive servoventilation was used for 10 months, the patient's growth began to improve.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  treatment-emergent central sleep apnea

Mesh:

Year:  2018        PMID: 29458694      PMCID: PMC5837850          DOI: 10.5664/jcsm.7004

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  13 in total

1.  Crossing the apnoeic threshold: causes and consequences.

Authors:  Jerome A Dempsey
Journal:  Exp Physiol       Date:  2004-11-30       Impact factor: 2.969

2.  The emergence of central sleep apnea after surgical relief of nasal obstruction in obstructive sleep apnea.

Authors:  Cathy Goldstein; Tomasz J Kuzniar
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

3.  The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy.

Authors:  Timothy I Morgenthaler; Tomasz J Kuzniar; Lisa F Wolfe; Leslee Willes; William C McLain; Rochelle Goldberg
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

4.  Bilevel positive airway pressure worsens central apneas during sleep.

Authors:  Karin G Johnson; Douglas C Johnson
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

5.  Development of a measure of knowledge and attitudes about obstructive sleep apnea in children (OSAKA-KIDS).

Authors:  Elizabeth C Uong; Donna B Jeffe; David Gozal; Raanan Arens; Cheryl R Holbrook; John Palmer; Claudia Cleveland; Helena M Schotland
Journal:  Arch Pediatr Adolesc Med       Date:  2005-02

6.  Effect of episodic hypoxia on the susceptibility to hypocapnic central apnea during NREM sleep.

Authors:  Susmita Chowdhuri; Irina Shanidze; Lisa Pierchala; Daniel Belen; Jason H Mateika; M Safwan Badr
Journal:  J Appl Physiol (1985)       Date:  2009-11-25

7.  Air leak during CPAP titration as a risk factor for central apnea.

Authors:  Sydney B Montesi; Jessie P Bakker; Mary Macdonald; Lauren Hueser; Stephen Pittman; David P White; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

8.  Secondary nocturnal enuresis caused by central sleep apnea from Chiari malformation type 1.

Authors:  Benjamin J Brown; Susanne Habelt; Korgun Koral; David Sacco; John H Herman; Linda A Baker
Journal:  J Pediatr Urol       Date:  2009-10-24       Impact factor: 1.830

9.  Adherence to and effectiveness of positive airway pressure therapy in children with obstructive sleep apnea.

Authors:  Carole L Marcus; Gerald Rosen; Sally L Davidson Ward; Ann C Halbower; Laura Sterni; Janita Lutz; Pamela J Stading; Daisy Bolduc; Nancy Gordon
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

10.  Obstructive sleep apnea: the use of nasal CPAP in 80 children.

Authors:  K A Waters; F M Everett; J W Bruderer; C E Sullivan
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.